Pharmacokinetics of the disialoganglioside, G(D2), a circulating tumor biomarker for neuroblastoma, in nonhuman primates

BACKGROUND: The ganglioside G(D2) is a potential circulating tumor biomarker for the childhood cancer neuroblastoma. Interpreting the levels of a circulating tumor biomarker depends in part on a knowledge of the biomarker’s clinical pharmacology. METHODS: We studied the plasma and cerebrospinal flui...

Descripción completa

Detalles Bibliográficos
Autores principales: Balis, Frank M., McCully, Cynthia Lester, Busch, Christine M., Fox, Elizabeth, Warren, Katherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655510/
https://www.ncbi.nlm.nih.gov/pubmed/34898668
http://dx.doi.org/10.33393/jcb.2021.2329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655510/
https://www.ncbi.nlm.nih.gov/pubmed/34898668
http://dx.doi.org/10.33393/jcb.2021.2329

Ejemplares similares